Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin or Any Other Oral Contraceptives (OC)).
Phase of Trial: Phase IV
Latest Information Update: 06 Mar 2012
At a glance
- Drugs Drospirenone/ethinylestradiol; Oral contraceptives
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Bayer
- 06 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Feb 2012 Planned end date changed from 1 Dec 2011 to 1 Mar 2012 as reported by ClinicalTrials.gov.
- 03 Nov 2011 Planned End Date changed from 1 Oct 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.